PTC Therapeutics, Inc. · Health Care
PTCT
$78.59
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.PTCTherapeutics,Inc.是一家美国制药公司，专注于开发口服小分子药物和基因疗法，通过靶向孤儿病中的转录后控制（PTC）机制来调节基因表达。
Rate-sensitive利率敏感
Mid cap中盘
$6B
Engine stance引擎立场2026-07-20
Neutral — no clear edge中性 — 无明显优势
The bottoming setup is not yet confirmed (price still below the 10-day average) and the 3-day/weekly momentum is rolling筑底形态尚未确认（价格仍位于 10 日均线下方），且3 日/周线动量已开始掉头向下——动量在形态完成前已开始衰竭。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Key Statistics关键统计
Price价格
$78.59
12.2% below 52-week high低于52周高点 12.2%
Market Cap市值
$6B
Normal volume正常成交量
P/E Ratio市盈率
9.4x
28.9x sector median
Beta贝塔
0.74
Moves about 0.7x the market波动幅度约为市场的 0.7 倍
RSI (14)RSI（14）
46
Neutral zone中性区域
Next Earnings下次财报
2026-08-06 (18d)
Volatility Rank波动率分位
48th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
21.2% of float
Performance价格表现
| Period周期 | PTCT | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -7.4% | -1.5% | Lagged the index by 5.9 points落后指数 5.9 个百分点 |
| 1 Month近1月 | +0.1% | +0.6% | In line with the index与指数基本持平 |
| 3 Months近3月 | +8.5% | +4.7% | Beat the index by 3.8 points跑赢指数 3.8 个百分点 |
| 6 Months近6月 | +8.4% | +7.8% | In line with the index与指数基本持平 |
| Year to date年初至今 | +2.4% | +9.1% | Lagged the index by 6.7 points落后指数 6.7 个百分点 |
| 1 Year近1年 | +61.9% | +19.4% | Beat the index by 42.5 points跑赢指数 42.5 个百分点 |
| 3 Years近3年 | +98.9% | +69.4% | Beat the index by 29.5 points跑赢指数 29.5 个百分点 |
Technicals技术面
RSI (14)RSI（14）
46
Neutral zone中性区域
vs 50-day相对50日均线
+3.1% vs 50-day avg
vs 200-day相对200日均线
+8.3% vs 200-day avg
Volatility rank波动率分位
48th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$76.09
Don't chase above不追高于
$78.59
Stop止损
$73.27
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
18
days until next report天后公布财报
2026-08-06
Estimates being raised — 1 analysts预期上调 — 1 位分析师
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | PTCT | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 9.37x | 28.92 | 97% |
| P/S市销率 | 3.70x | 3.02 | 41% |
| Earnings yield盈利收益率 | 10.67% | 2.72 | 98% |
| FCF yield自由现金流收益率 | 10.97% | 3.94 | 93% |
| EV/EBITDA企业价值/EBITDA | 6.61x | 18.21 | 95% |
| P/FCF市值/自由现金流 | 9.12x | 22.42 | 91% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 35.4%
Earnings Per Share每股收益
Free Cash Flow自由现金流
Margins利润率
-332.7%Return on Equity股本回报率
23.6%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -0.46 |
| Current ratio流动比率 | 2.35 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $74.5M |
| Share count change (1y)股数变化（1年） | +4.9% |
Piotroski皮奥特罗斯基 6/8
Altman Z阿尔特曼Z: grey (1.9)
Watch关注
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Looks cheap vs sector相对行业偏便宜
Cheaper than 82% of its sector on blended multiples综合估值倍数低于行业内 82% 的公司
Beta市场敏感度
0.74×
0.21×3×
Moves about 0.7× the market波动幅度约为市场的 0.7 倍
Financial Health财务健康
6/8
Altman阿尔特曼: grey
Adequate financial health财务健康状况一般
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed +46.9%空头仓位变动 +46.9%
Technical技术面
PTCT daily MACD crossed downPTCT 日线MACD下穿
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$36.6M net (0 buyers, 11 sellers)-$36.6M 净值（0 买家，11 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| RTW Investments | B | Holding持有 | 5.2% | 2026-03-31 |
Signal History信号历史
TURN SIGNALED
BOTTOMING
Jul 13, 2026
PTCT daily MACD crossed downPTCT 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $81.33.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$81.33。
Jul 9, 2026
PTCT made a new 52-week highPTCT 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $89.55.价格创出52周新高 — 全市场关注的动量/趋势极值。$89.55。
Jul 7, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Jul 7, 2026
PTCT made a new 52-week highPTCT 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $89.20.价格创出52周新高 — 全市场关注的动量/趋势极值。$89.20。
Jul 7, 2026
PTCT RSI reached overboughtPTCT RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $89.20.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$89.20。
Jul 6, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jul 2, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 1, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jun 30, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Showing last 15 of显示最近15条，共 239 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.84
Value价值
-0.5
Quality质量
+0.4
Investment资本投入
-3.0
Low volatility低波动
-0.3
Low market beta低市场敏感度
+0.1
Earnings quality盈利质量
-0.6
Short interest空头兴趣
-2.0
Company Profile公司档案
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.PTCTherapeutics,Inc.是一家美国制药公司，专注于开发口服小分子药物和基因疗法，通过靶向孤儿病中的转录后控制（PTC）机制来调节基因表达。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Inventory build
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。